Company Updates
Australian Equities Value Strategy Out-Performs the All Ordinaries Index by ~16% After Fees for the 3 Month Period to 31 May 2020.
Collins St Asset Management are pleased to announce that, following a +13% net monthly return for April their flagship Collins St Value Fund has produced another +13% net monthly return in May
SWAN Systems One Step Closer to Becoming Market Leader in Irrigation Software
SWAN Systems is excited to announce the launch of its latest software module, System Suggested Irrigation (SSI); a new feature that can now be sent out to irrigation controllers to automatically…
Revolutionary Sleeping Pods with Global Traveller Data Capture, Online Sales via App, and Global Intellectual Property Protection
“Smart Bunks is a start-up business which has designed a modern and innovative bunk bed for the backpacker industry to replace the decades old metal bunks. It is a massive global opportunity..”
Allied BioScience disinfectant kills coronavirus for 90 days: study
A specially formulated antimicrobial coating can keep surfaces clear of a human coronavirus for up to 90 days with just one application.
Noviscient Closes Venture Round & Announces Launch of Fund
Noviscient Limited is please to announce the close of the final Venture Capital investment round in May, 2020 and the upcoming launch of the Noviscient Pure Alpha Fund on July 1st, 2020.
Mortgage Fintech Funding.com.au Raises $5 Million Warehouse to Bring Alternatives to Cautious Investors
Funding.com.au, an online mortgage marketplace, has raised a $5 million AUD warehouse from local venture capital fund Equity Venture Partners (EVP) to bring its secured lending platform to investors
Stropro Australia’s First Dedicated Investment Platform for Structured Products
The Stropro platform provides access to Structured products to Australian wholesale investors.
For decades across the globe, high net worth investors have been utilising structured products…
Tessara Therapeutics Raises $2.7 Million to Develop Mimetic Brain Tissue
Tessara™Therapeutics Pty Ltd closed their Round 1 capital raise with $2.7M invested, significantly over-subscribed by Australian and New Zealand-based sophisticated investors.
Backed By Leading Investment Groups and Family Offices
